Response to SARS-Covid-19-related visitor restrictions on labor and delivery wards in New York City

Alison Hermann; Kristina M. Deligiannidis; Veerle Bergink; Catherine Monk; Elizabeth M. Fitelson; Thalia K. Robakis; Catherine Birndorf

doi:10.1007/s00737-020-01030-2

Response to SARS-Covid-19-related visitor restrictions on labor and delivery wards in New York City

Alison Hermann
, Kristina M. Deligiannidis
, Veerle Bergink
, Catherine Monk
, Elizabeth M. Fitelson
, Thalia K. Robakis
, Catherine Birndorf

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English
Pages (from-to)	793-794
Number of pages	2
Journal	Archives of Women's Mental Health
Volume	23
Issue number	6
DOIs	https://doi.org/10.1007/s00737-020-01030-2
State	Published - Dec 2020

Access to Document

10.1007/s00737-020-01030-2

Cite this

@article{c79729637de84932a35c88a0aede9fe1,

title = "Response to SARS-Covid-19-related visitor restrictions on labor and delivery wards in New York City",

author = "Alison Hermann and Deligiannidis, \{Kristina M.\} and Veerle Bergink and Catherine Monk and Fitelson, \{Elizabeth M.\} and Robakis, \{Thalia K.\} and Catherine Birndorf",

note = "Funding Information: Dr. Hermann served as a consultant for Sage Therapeutics and is a cofounder and chief medical officer of Iris OB Health, Inc. Dr. Deligiannidis receives research grant support from NIMH, Sage Therapeutics and Vorso Corporation, serves as a consultant to Sage Therapeutics, and receives royalties from an NIH Employee Invention. Dr. Robakis receives research grant support from Vorso Corporation. Dr. Birndorf is CEO of The Motherhood Center of New York. ",

year = "2020",

month = dec,

doi = "10.1007/s00737-020-01030-2",

language = "English",

volume = "23",

pages = "793--794",

journal = "Archives of Women's Mental Health",

issn = "1434-1816",

publisher = "Springer",

number = "6",

}

TY - JOUR

T1 - Response to SARS-Covid-19-related visitor restrictions on labor and delivery wards in New York City

AU - Hermann, Alison

AU - Deligiannidis, Kristina M.

AU - Bergink, Veerle

AU - Monk, Catherine

AU - Fitelson, Elizabeth M.

AU - Robakis, Thalia K.

AU - Birndorf, Catherine

N1 - Funding Information: Dr. Hermann served as a consultant for Sage Therapeutics and is a cofounder and chief medical officer of Iris OB Health, Inc. Dr. Deligiannidis receives research grant support from NIMH, Sage Therapeutics and Vorso Corporation, serves as a consultant to Sage Therapeutics, and receives royalties from an NIH Employee Invention. Dr. Robakis receives research grant support from Vorso Corporation. Dr. Birndorf is CEO of The Motherhood Center of New York.

PY - 2020/12

Y1 - 2020/12

UR - https://www.scopus.com/pages/publications/85083445542

U2 - 10.1007/s00737-020-01030-2

DO - 10.1007/s00737-020-01030-2

M3 - Letter

C2 - 32296947

AN - SCOPUS:85083445542

SN - 1434-1816

VL - 23

SP - 793

EP - 794

JO - Archives of Women's Mental Health

JF - Archives of Women's Mental Health

IS - 6

ER -